The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network
Open accessAbstract
OBJECTIVE: White matter hyperintensities (WMHs) are areas of increased signal on T2-weighted magnetic resonance imaging (MRI) scans that most commonly reflect small vessel cerebrovascular disease. Increased WMH volume is associated with risk and progression of Alzheimer's disease (AD). These observations are typically interpreted as evidence that vascular abnormalities play an additive, independent role contributing to symptom presentation, but not core features of AD. We examined the severity and distribution of WMH in presymptomatic PSEN1, PSEN2, and APP mutation carriers to determine the extent to which WMH manifest in individuals genetically determined to develop AD. METHODS: The study comprised participants (n = 299; age = 39.03 ± 10.13) from the Dominantly Inherited Alzheimer Network, including 184 (61.5%) with a mutation that results in AD and 115 (38.5%) first-degree relatives who were noncarrier controls. We calculated the estimated years from expected symptom onset (EYO) by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were analyzed for total and regional WMH. Mixed-effects piece-wise linear regression was used to examine WMH differences between carriers and noncarriers with respect to EYO. RESULTS: Mutation carriers had greater total WMH volumes, which appeared to increase approximately 6 years before expected symptom onset. Effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years before estimated onset. INTERPRETATION: Autosomal-dominant AD is associated with increased WMH well before expected symptom onset. The findings suggest the possibility that WMHs are a core feature of AD, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease. Ann Neurol 2016;79:929-939.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“findings from previous studies have also shown that WMHs often occur prior to the presence of amyloid-β plaques in preclinical AD [19,20,21]”
From Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function (2023) · cites this paper as [19]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence suggests that white matter microstructural changes may be not only a marker of small vessel injury but also directly related to AD pathology. 53 , 54”
From White matter hyperintensity modulates the amyloid‐tau‐cognition association and anti‐amyloid treatment efficacy in asymptomatic older adults (2025) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“WMHs are considered an MRI detectable marker of white matter changes due to microvascular pathology, and are increased in autosomal-dominant Alzheimer’s disease (Lee et al., 2016).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Lee et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust Locally Weighted Regression and Smoothing Scatterplots
Cleveland, W. S. (1979) · Journal of the American Statistical Association · doi:10.1080/01621459.1979.10481038 · Cited by 11,594
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Self-citationGorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Regional Brain Changes in Aging Healthy Adults: General Trends, Individual Differences and Modifiers
Raz, N., Lindenberger, U., Rodrigue, K. M., Kennedy, K. M., Head, D., Williamson, A., Dahle, C., Gerstorf, D., & Acker, J. D. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhi044 · Cited by 2,875
Debette, S., & Markus, H. S. (2010) · BMJ · doi:10.1136/bmj.c3666 · Cited by 2,328
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1080/01621459.1970.10481147 · DOI
Cited by
Sorted by citations
Items 101–200 of 542
Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer’s disease
Gao, Y., Sengupta, A., Li, M., Zu, Z., Rogers, B. P., Anderson, A. W., Ding, Z., Gore, J. C., & Initiative, A. D. N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240513 · Cited by 58
Andrew, R. J., De Rossi, P., Nguyen, P., Kowalski, H. R., Recupero, A. J., Guerbette, T., Krause, S. V., Rice, R. C., Laury-Kleintop, L., Wagner, S. L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006379 · Cited by 55
Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease
Kalaria, R. N., & Falla, D. S. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.004 · Cited by 56
Clinical considerations in early-onset cerebral amyloid angiopathy
Banerjee, G., Collinge, J., Fox, N. C., Lashley, T., Mead, S., Schott, J. M., Werring, D. J., & Ryan, N. S. (2023) · Brain · doi:10.1093/brain/awad193 · Cited by 54
Swardfager, W., Yu, D., Ramirez, J., Cogo‐Moreira, H., Szilagyi, G. M., Holmes, M. F., Scott, C. J. M., Scola, G., Chan, P. C., Chen, J., et al. (2017) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.011 · Cited by 53
Brain Vasculature and Cognition
Fouda, A. Y., Fagan, S. C., & Ergul, A. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311906 · Cited by 53
White matter hyperintensities are associated with subthreshold amyloid accumulation
Moscoso, A., Rey-Bretal, D., Silva-Rodríguez, J., Aldrey, J. M., Cortés, J., Pías-Peleteiro, J., Ruibal, Á., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116944 · Cited by 49
“In familial AD, frontal and posterior WMH seem to emerge earlier in the disease course (Lee et al., 2016), in line with fi ndings from a neuro-imaging study which suggests that spatial patterns of amyloid-related WMH are different from those of vascular aetiology (Al-Janabi et al., 2018) and…”
InfluentialNeuroimaging in aging and neurologic diseases
Risacher, S. L., & Saykin, A. J. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00012-1 · Cited by 56
Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities
Osborn, K. E., Liu, D., Samuels, L. R., Moore, E. E., Cambronero, F. E., Acosta, L. M. Y., Bell, S. P., Babicz, M. A., Gordon, E. A., Pechman, K. R., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.028 · Cited by 51
Ivanova, N., Liu, Q., Agca, C., Ağca, Y., Noble, E. G., Whitehead, S. N., & Cechetto, D. F. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1698-7 · Cited by 51
Caballero, M. Á. A., Song, Z., Rubinski, A., Duering, M., Dichgans, M., Park, D. C., & Ewers, M. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12062 · Cited by 52
Forooshani, P. M., Biparva, M., Ntiri, E. E., Ramirez, J., Boone, L., Holmes, M. F., Adamo, S. M., Gao, F., Ozzoude, M., Scott, C. J. M., et al. (2022) · Human Brain Mapping · doi:10.1002/hbm.25784 · Cited by 54
Prospective biomarkers of Alzheimer’s disease: A systematic review and meta-analysis
Li, R., Ma, Y., Tan, L., & Yu, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101699 · Cited by 54
Walsh, P., Sudre, C. H., Fiford, C. M., Ryan, N. S., Lashley, T., Frost, C. D., & Barnes, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.03.008 · Cited by 49
CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease
Pietroboni, A. M., Scarioni, M., Carandini, T., Basilico, P., Cadioli, M., Giulietti, G., Arighi, A., Caprioli, M., Serra, L., Sina, C., et al. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316603 · Cited by 47
Vonk, J. M. J., Bouteloup, V., Mangin, J., Dubois, B., Blanc, F., Gabelle, A., Ceccaldi, M. P., Annweiler, C., Krolak‐Salmon, P., Belin, C., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12066 · Cited by 48
Stefanovski, L., Meier, J. M., Pai, R. K., Triebkorn, P., Lett, T. A. P., Martin, L., Bülau, K., Hofmann‐Apitius, M., Solodkin, A., McIntosh, A. R., et al. (2021) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2021.630172 · Cited by 47
Are the brain's vascular and Alzheimer pathologies additive or interactive?
Koncz, R., & Sachdev, P. S. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000395 · Cited by 47
The effect of white matter hyperintensities on verbal memory
Swardfager, W., Cogo‐Moreira, H., Masellis, M., Ramirez, J., Herrmann, N., Edwards, J. D., Saleem, M., Chan, P., Yu, D., Nestor, S. M., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000004983 · Cited by 47
Cognitive functioning in chronic post-stroke aphasia
Fonseca, J., Raposo, A., & Martins, I. P. (2018) · Applied Neuropsychology Adult · doi:10.1080/23279095.2018.1429442 · Cited by 47
Model-based whole-brain perturbational landscape of neurodegenerative diseases
Perl, Y. S., Fittipaldi, S., Campo, C. G., Moguilner, S., Cruzat, J., Fraile-Vazquez, M. E., Herzog, R. A., Kringelbach, M. L., Deco, G., Prado, P., et al. (2023) · eLife · doi:10.7554/elife.83970 · Cited by 47
Viscoelastic Properties of Human Autopsy Brain Tissues as Biomarkers for Alzheimer's Diseases
Park, K., Lonsberry, G. E., Gearing, M., Levey, A. I., & Desai, J. P. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2018.2878555 · Cited by 47
Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET
Ottoy, J., Ozzoude, M., Zukotynski, K., Adamo, S. M., Scott, C. J. M., Gaudet, V., Ramirez, J., Swardfager, W., Cogo‐Moreira, H., Lam, B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12750 · Cited by 48
High burden of cerebral white matter lesion in 9 Asian cities
Lam, B. Y. K., Yiu, B., Ampil, E. R., Chen, C., Dikot, Y., Dominguez, J. C., Ganeshbhai, P. V., Hilal, S., Kandiah, N., Kim, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-90746-x · Cited by 45
Cajamarca, S. A., Norris, E. H., van der Weerd, L., Strickland, S., & Ahn, H. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921327117 · Cited by 45
McKay, N. S., Gordon, B. A., Hornbeck, R. C., Dincer, A., Flores, S. E., Keefe, S., Joseph‐Mathurin, N., Jack, C. R., Koeppe, R. A., Millar, P. R., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01359-8 · Cited by 44
Huynh, K., Piguet, O., Kwok, J., Dobson-Stone, C., Halliday, G. M., Hodges, J. R., & Landin-Romero, R. (2021) · Neurology · doi:10.1212/wnl.0000000000011638 · Cited by 43
Kapoor, A., Gaubert, A., Marshall, A. J., Meier, I. B., Yew, B., Ho, J. K., Blanken, A. E., Dutt, S., Sible, I. J., Li, Y., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.711784 · Cited by 42
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Boyce, G. K., Button, E. B., Sonja, S. V., & Wellington, C. L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41
Characterizing a perfusion-based periventricular small vessel region of interest
Dolui, S., Tisdall, M. D., Vidorreta, M., Jacobs, D. R., Nasrallah, I. M., Bryan, R. N., Wolk, D. A., & Detre, J. A. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101897 · Cited by 43
Artificial intelligence for dementia research methods optimization
Bucholc, M., James, C. R., Khleifat, A. A., Badhwar, A., Clarke, N., Dehsarvi, A., Madan, C. R., Marzi, S. J., Shand, C., Schilder, B. M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13441 · Cited by 49
Zhang, J., Chen, H., Wang, J., Huang, Q., Xu, X., Wang, W., Xu, W. L., Guan, Y., Liu, J., Wardlaw, J. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13845 · Cited by 40
Amyloid Positivity in the Alzheimer/Subcortical-Vascular Spectrum
Kang, S. H., Kim, M. E., Jang, H., Kwon, H., Lee, H., Kim, H. J., Seo, S. W., & Na, D. L. (2021) · Neurology · doi:10.1212/wnl.0000000000011833 · Cited by 41
Wang, S., Jiang, Y. X., Liu, Y., Liu, Q., Sun, H., Mei, M., & Liao, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02731-8 · Cited by 40
Low, A., Prats‐Sedano, M. A., McKiernan, E. F., Carter, S. F., Stefaniak, J. D., Nannoni, S., Su, L., Dounavi, M., Terrera, G. M., Ritchie, K. A., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01095-4 · Cited by 40
Vasodilator dysfunction and oligodendrocyte dysmaturation in aging white matter
Bagi, Z. A., Brandner, D. D., Le, P., McNeal, D. W., Gong, X., Dou, H., Fulton, D. J., Beller, A., Ngyuen, T. D., Larson, E. B., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25129 · Cited by 41
Tarumi, T., Thomas, B. P., Tseng, B. Y., Wang, C., Womack, K. B., Hynan, L. S., Lu, H., Cullum, C. M., & Zhang, R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190875 · Cited by 45
White matter alterations in Alzheimer’s disease without concomitant pathologies
Ferrer, I., & Andrés‐Benito, P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12618 · Cited by 38
Rujeedawa, T., Félez, E. C., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A., Coppus, A. M. W., Levin, J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194582 · Cited by 43
Vemuri, P., DeCarli, C. S., & Duering, M. (2022) · Stroke · doi:10.1161/strokeaha.120.032611 · Cited by 46
Huang, P., & Zhang, M. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00905-x · Cited by 40
Bangen, K. J., Thomas, K. R., Weigand, A. J., Sanchez, D. L., Delano‐Wood, L., Edmonds, E. C., Carmichael, O. T., Schwarz, C. G., Brickman, A. M., & Bondi, M. W. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.016 · Cited by 38
Biesbroek, J. M., Coenen, M., DeCarli, C., Fletcher, E. M., Maillard, P. M., Initiative, A. D. N., Barkhof, F., Barnes, J., Benke, T., Chen, C. P. L. H., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13765 · Cited by 38
Swardfager, W., Yu, D., Scola, G., Cogo‐Moreira, H., Chan, P., Zou, Y. Z., Herrmann, N., Lanctôt, K. L., Ramirez, J., Gao, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.029 · Cited by 38
Ramamurthy, E., Welch, G., Cheng, J., Yuan, Y., Gunsalus, L. M., Bennett, D. A., Tsai, L., & Pfenning, A. R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.948456 · Cited by 39
Hayden, E. Y., Putman, J. N., Nuñez, S., Shin, W. S., Oberoi, M. R., Charreton, M., Dutta, S., Li, Z., Komuro, Y., Joy, M. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0783-6 · Cited by 37
The association between white matter hyperintensities and amyloid and tau deposition
Alban, S. L., Lynch, K. M., Ringman, J. M., Toga, A. W., Chui, H. C., Sepehrband, F., & Choupan, J. (2023) · NeuroImage: Clinical · doi:10.1016/j.nicl.2023.103383 · Cited by 35
Self-citationLorenzini, L., Maranzano, A., Ingala, S., Collij, L. E., Tranfa, M., Blennow, K., Perri, C. D., Foley, C., Fox, N. C., Frisoni, G. B., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209801 · Cited by 36
Mito, R., Dhollander, T., Xia, Y., Raffelt, D. A., Salvado, O., Churilov, L. P., Rowe, C. C., Brodtmann, A. G., Villemagne, V. L., & Connelly, A. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102479 · Cited by 37
Luo, J., Ma, Y., Agboola, F. J., Grant, E., Morris, J. C., McDade, E., Fagan, A. M., Benzinger, T. L. S., Hassenstab, J., Bateman, R. J., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207378 · Cited by 35
Self-citationWhite matter hyperintensities in former American football players
Alosco, M. L., Tripodis, Y., Baucom, Z., Adler, C. H., Balcer, L. J., Bernick, C. B., Mariani, M. L., Au, R., Banks, S. J., Barr, W., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12779 · Cited by 35
Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA
Sin, M., ZAMRINI, E. Y., Ahmed, A., Nho, K. T., & Hajjar, I. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216792 · Cited by 39
Vangberg, T. R., Eikenes, L., & Haberg, A. K. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116158 · Cited by 37
Ferreira, S., Pitman, K. A., Wang, S., Summers, B. S., Bye, N., Young, K. M., & Cullen, C. L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24672 · Cited by 38
Schoemaker, D., Zotin, M. C. Z., Chen, K., Igwe, K. C., Vila‐Castelar, C., Martinez, J. E., Baena, A. Y., Fox‐Fuller, J. T., Lopera, F. J., Reiman, E. M., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01030-7 · Cited by 32
A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer’s disease
Chen, Z., Singh, P. K., Calvano, M., Norris, E. H., & Strickland, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2309389120 · Cited by 34
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
Dincer, A., Gordon, B. A., Hari‐Raj, A., Keefe, S., Flores, S. E., McKay, N. S., Paulick, A. M., Shady, K., Feldman, R. L., Hornbeck, R. C., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102491 · Cited by 36
Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD
Kamal, F., Morrison, C., Maranzano, J., Zeighami, Y., Dadar, M., & Initiative, A. D. N. (2022) · GeroScience · doi:10.1007/s11357-022-00665-6 · Cited by 34
SegAE: Unsupervised white matter lesion segmentation from brain MRIs using a CNN autoencoder
Atlason, H. E., Löve, Á., Sigurdsson, S. O., Gudnason, V. G., & Ellingsen, L. M. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102085 · Cited by 33
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
Moscoso, A., Silva‐Rodríguez, J., Aldrey, J. M., Cortés, J., Peleteiro, J. M. P., Ruibal, Á., Aguiar, P., & Initiative, A. D. N. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05493-y · Cited by 37
Xu, Y., Liu, X., Shen, J., Tian, W., Fang, R., Li, B., Ma, J., Cao, L. H., Chen, S., Li, G., et al. (2018) · Aging and Disease · doi:10.14336/ad.2018.0208 · Cited by 33
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
Alosco, M. L., Duskin, J. A., Besser, L. M., Martin, B. M., Chaisson, C. E., Gunstad, J., Kowall, N. W., McKee, A. C., Stern, R. A., & Tripodis, Y. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161205 · Cited by 32
Clark, A. L., Weigand, A. J., Bangen, K. J., Merritt, V. C., Bondi, M. W., & Delano‐Wood, L. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19897443 · Cited by 35
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences
Baazaoui, N., & Iqbal, K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220105 · Cited by 35
Hijazi, Z., Yassi, N., O'Brien, J. T., & Watson, R. (2021) · European Journal of Neurology · doi:10.1111/ene.15211 · Cited by 31
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Krey, L., Huber, M. K., Höglinger, G. U., & Wegner, F. (2021) · Brain Sciences · doi:10.3390/brainsci11121654 · Cited by 31
Song, J. (2024) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2024.13.2.122 · Cited by 31
White matter hyperintensities and cognition across different Alzheimer's biomarker profiles
Lam, S., Lipton, R. B., Harvey, D. J., Zammit, A. R., Ezzati, A., & Initiative, A. D. N. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17173 · Cited by 30
Uretsky, M., Sylvain Bouix, A., Killiany, R., Tripodis, Y., Martin, B. M., Palmisano, J. N., Mian, A. Z., Buch, K. A., Farris, C. W., Daneshvar, D. H., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013012 · Cited by 32
Liu, Z., Chao, J., Wang, C., Sun, G., Roeth, D., Liu, W., Chen, X., Li, L., Tian, E., Feng, L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112841 · Cited by 30
Houck, A. L., Gutierrez, J., Gao, F., Igwe, K. C., Colón, J. M., Black, S. E., & Brickman, A. M. (2019) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6213 · Cited by 31
Association of white matter hyperintensities with cognitive decline and neurodegeneration
Li, T., Li, B.-L., Xu, X., Zhong, J., Wang, T.-S., Liu, F., & Initiative, T. A. D. N. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1412735 · Cited by 35
Edwards, N. C., Lao, P. J., Alshikho, M. J., Ericsson, O. M., Rizvi, B. M., Petersen, M. E., O’Bryant, S. E., Aguilar, L. F., Simoes, S., Mapstone, M. E., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae331 · Cited by 34
Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature
Bieri, G., Pratt, K. J. B., Fuseya, Y., Aghayev, T., Sucharov, J., Horowitz, A. M., Philp, A. R., Fonseca-Valencia, K., Chu, R., Phan, M., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.024 · Cited by 35
Dementia: Paradigm shifting into high gear
Hachinski, V. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.01.006 · Cited by 30
Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer’s Disease
Yassi, N., Hilal, S., Xia, Y., Lim, Y. Y., Watson, R., Kuijf, H. J., Fowler, C. J., Yates, P. A., Maruff, P. T., Martins, R. N., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-191028 · Cited by 31
Pietroboni, A. M., Colombi, A., Carandini, T., Scarpini, E. A., Galimberti, D., & Bozzali, M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200868 · Cited by 30
Vesperman, C. J., Pozorski, V., Dougherty, R. J., Law, L. L., Boots, E. A., Oh, J. M., Gallagher, C. L., Carlsson, C. M., Rowley, H. A., Ma, Y., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0429-0 · Cited by 28
Sharp, F. R., DeCarli, C. S., Jin, L., & Zhan, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096206 · Cited by 33
Cogswell, P. M., Lundt, E. S., Therneau, T. M., Mester, C. T., Wiste, H. J., Graff‐Radford, J., Schwarz, C. G., Senjem, M. L., Gunter, J. L., Reid, R. I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38878-8 · Cited by 29
Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
Colvee-Martin, H., Parra, J. R., Gonzalez, G. A., Barker, W., & Duara, R. (2024) · Diagnostics · doi:10.3390/diagnostics14070704 · Cited by 32
Cerebrovascular disease emerges with age and Alzheimer’s disease in adults with Down syndrome
Lao, P. J., Edwards, N., Aguilar, L. F., Alshikho, M. J., Rizvi, B. M., Tudorascu, D., Rosas, H. D., Yassa, M. A., Christian, B., Mapstone, M. E., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61962-y · Cited by 30
Besser, L. M., Alosco, M. L., Gomez, L. A. R., Zhou, X., McKee, A. C., Stern, R. A., Gunstad, J., Schneider, J. A., Chui, H. C., & Kukull, W. A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw072 · Cited by 29
Autosomal dominantly inherited alzheimer disease: Analysis of genetic subgroups by machine learning
Castillo-Barnés, D., Su, L., Ramírez, J., Salas-Gonzalez, D., Martínez-Murcia, F. J., Illán, I. A., Segovia, F., Ortíz, A., Cruchaga, C., Farlow, M. R., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.01.001 · Cited by 29
Circulating metabolites are associated with brain atrophy and white matter hyperintensities
de Leeuw, F. A., Karamujić‐Čomić, H., Tijms, B. M., Peeters, C. F. W., Kester, M. I., Scheltens, P., Ahmad, S., Vojinović, D., Adams, H. H. H., Hankemeier, T., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12180 · Cited by 28
Walsh, P., Sudre, C. H., Fiford, C. M., Ryan, N. S., Lashley, T., Frost, C. D., & Barnes, J. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.09.008 · Cited by 29
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
Joseph‐Mathurin, N., Wang, G., Kantarci, K., Jack, C. R., McDade, E., Hassenstab, J. J., Blazey, T., Gordon, B. A., Su, Y., Chen, G., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011542 · Cited by 28
Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease
Òbis, È., Sol, J., Andrés‐Benito, P., Martin‐Garí, M., Mota‐Martorell, N., Galo‐Licona, J. D., Piñol‐Ripoll, G., Portero‐Otín, M., Ferrer, I., Jové, M., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0217 · Cited by 28
Recent advances in neuroimaging of Alzheimer's disease and related dementias
Ottoy, J., Owsicki, N., Bilgel, M., Binette, A. P., Salvadó, G., Kang, M. S., Cash, D. M., Ewers, M., Joie, R. L., Wisse, L. E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70648 · Cited by 30
Levit, A., Regis, A. M., Gibson, A., Hough, O., Maheshwari, S., Ağca, Y., Agca, C., Hachinski, V., Allman, B. L., & Whitehead, S. N. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.013 · Cited by 27
Roseborough, A. D., Langdon, K. D., Hammond, R. R., Cipriano, L. E., Pasternak, S., Whitehead, S. N., & KHAN, A. R. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102340 · Cited by 25
Association of cerebral microvascular dysfunction and white matter injury in Alzheimer’s disease
Bagi, Z. A., Kroenke, C. D., Fopiano, K. A., Tian, Y., Filosa, J. A., Sherman, L. S., Larson, E. B., Keene, C. D., Degener-O’Brien, K., Adeniyi, P. A., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00585-5 · Cited by 27
Assessment of white matter hyperintensity severity using multimodal magnetic resonance imaging
Parent, O., Bussy, A., Devenyi, G. A., Dai, A., Costantino, M., Tullo, S., Salaciak, A., Bedford, S. A., Farzin, S., Béland, M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad279 · Cited by 24
Current and Future Treatments of Vascular Cognitive Impairment
Ip, B. Y. M., Ko, H., Lam, B. Y. K., Au, L. W. C., Lau, A. Y. L., Huang, J., Kwok, A. J., Leng, X., Cai, Y., Leung, T. W. H., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.044174 · Cited by 27
Modeling Alzheimer’s disease using human cell derived brain organoids and 3D models
Fernandes, S., Revanna, J. S., Pratt, J. M., Hayes, N., Marchetto, M. C., & Gage, F. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1434945 · Cited by 33
The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks
Constantino, N. J., Ashley, C. C., & Macauley, S. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70294 · Cited by 29
Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β 1-42 and Hypertension
Al‐Janabi, O. M., Brown, C. A., Bahrani, A. A., Abner, E. L., Barber, J. M., Gold, B. T., Goldstein, L. B., Murphy, R. R., Nelson, P. T., Johnson, N. F., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180663 · Cited by 27
The convergence of stroke and dementia
Hachinski, V. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180148 · Cited by 26
Icariin Ameliorates Alzheimer’s Disease Pathology by Alleviating Myelin Injury in 3 × Tg-AD Mice
Yu, H., Shi, J., Lin, Y., Zhang, Y., Luo, Q., Huang, S., Wang, S., Wei, J., Huang, J., Li, C., et al. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03507-7 · Cited by 25
Metadata
- Authors
- Lee, S., Viqar, F., Zimmerman, M. E., Narkhede, A., Tosto, G., Benzinger, T. L. S., Marcus, D. S., Fagan, A. M., Goate, A., Fox, N. C., Cairns, N. J., Holtzman, D. M., Buckles, V., Ghetti, B., McDade, E., Martins, R. N., Saykin, A. J., Masters, C. L., Ringman, J. M., Ryan, N. S., Förster, S., Laske, C., Schofield, P. R., Sperling, R. A., Salloway, S., Correia, S., Jack, C., Weiner, M., Bateman, R. J., Morris, J. C., Mayeux, R., Brickman, A. M., & for the Dominantly Inherited Alzheimer Network
- Affiliations
- New York State Psychiatric Institute (US)
- Fordham University (US)
- Albert Einstein College of Medicine (US)
- Columbia University Irving Medical Center (US)
- NewYork–Presbyterian Hospital (US)
- Washington University in St. Louis (US)
- Icahn School of Medicine at Mount Sinai (US)
- UCL Queen Square Institute of Neurology (GB)
- Indiana University Indianapolis (US)
- Edith Cowan University (AU)
- The University of Melbourne (AU)
- University of Southern California (US)
- German Center for Neurodegenerative Diseases (DE)
- UNSW Sydney (AU)
- Brigham and Women's Hospital (US)
- Brown University (US)
- Mayo Clinic (US)
- San Francisco VA Medical Center (US)
- Corresponding author
- Brickman, Adam M.
- ORCID
- Lee, Seonjoo
- Zimmerman, Molly E.
- Tosto, Giuseppe
- Benzinger, Tammie L.S.
- Marcus, Daniel S.
- Fagan, Anne M.
- Goate, Alison
- Fox, Nick C.
- Holtzman, David M.
- Ghetti, Bernardino
- McDade, Eric
- Martins, Ralph N.
- Saykin, Andrew J.
- Masters, Colin L.
- Ringman, John M.
- Ryan, Natalie S.
- Förster, Stefan
- Laske, Christoph
- Schofield, Peter R.
- Sperling, Reisa A.
- Salloway, Stephen
- Correia, Stephen
- Jack, Clifford
- Weiner, Michael
- Bateman, Randall J.
- Morris, John C.
- Mayeux, Richard
- Brickman, Adam M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2016-04-27
- Volume
- 79
- Issue
- 6
- Pages
- 929-939
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC4884146
- OpenAlex
- W2309640507
- Cited by
- 542
- References
- 51
- Citations by year
- 2026: 49 · 2025: 58 · 2024: 53 · 2023: 68 · 2022: 65 · 2021: 65 · 2020: 66 · 2019: 46 · 2018: 38 · 2017: 25 · 2016: 8
- FWCI
- 34.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UNSWorks (UNSW Sydney) (submittedVersion, cc-by-nc-nd)
- Australasian Journal of Paramedicine (submittedVersion)
- Deep Blue (University of Michigan) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- PMC
- Funders
- NIH/NIA (U19 AG032438, AG051348)
- NIHR Queen Square Dementia BRU
- German Center for Neurodegenerative Diseases (DZNE)
- Brain Exit Foundation Fellowship
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- white matter hyperintensities, Alzheimer's disease, autosomal dominant Alzheimer's disease, presymptomatic carriers, presenilin 1, presenilin 2, APP, cerebral small vessel disease, genetic risk
- MeSH terms
- Adult, Alzheimer Disease, Female, Heterozygote, Humans, Magnetic Resonance Imaging, Male, Peptide Fragments, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Genetic Predisposition to Disease, Presenilin-1, Presenilin-2, Young Adult, Neuroimaging, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
